DYN

Dyne Therapeutics, Inc.

Healthcare · Biotechnology

$271.59 sample

-4.46 (-1.62%) 1D

Market cap

$389.3B

Price as of

2026-10-15

Latest filing

8-K · 2026-08-19

Alerts

8

Price$271.59 +2.32% 3M daily closessample

290.74262.31

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 05INSInsider buy: General Counsel
Sep 29INSInsider buy: EVP, Operations
Sep 21INSInsider buy: Chief Financial Officer
Sep 15INSInsider sell: EVP, Operations
Sep 07INSInsider sell: Chief Executive Officer
Aug 27INSInsider sell: Director
Aug 19SECDEF 14A filed
Aug 13INSInsider buy: EVP, Operations

Sign up to see the real DYN record →

Company facts

SEC EDGAR registration

Name: Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -34sample, -100 to +100
Reporting currency: USD

Who is positioning in DYN

sample

Insiders: 34 insider transactions over 90 days, net selling, $468.2M
Congress: 3 members traded over 90 days
Institutions · 13F: 43 funds hold $9.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$11.3B +10.3% y/y

Q4 2024Q3 2026

Inventory$7.1B +17.8% y/y

Q4 2024Q3 2026

Accounts receivable$5.0B +5.4% y/y

Q4 2024Q3 2026

Total debt$13.4B +9.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $328.2B -1.2% 3M
Sample peer B: $356.9B +13.3% 3M
Sample peer C: $239.0B +13.3% 3M
Sample peer D: $384.4B -7.7% 3M
Sample peer E: $256.5B +0.8% 3M